Cargando…
How US law will evaluate artificial intelligence for covid-19
Daniel E Ho and colleagues explore the legal implications of using artificial intelligence in the response to covid-19 and call for more robust evaluation frameworks
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958498/ https://www.ncbi.nlm.nih.gov/pubmed/33722811 http://dx.doi.org/10.1136/bmj.n234 |
| _version_ | 1783664829613998080 |
|---|---|
| author | Krass, Mark Henderson, Peter Mello, Michelle M Studdert, David M Ho, Daniel E |
| author_facet | Krass, Mark Henderson, Peter Mello, Michelle M Studdert, David M Ho, Daniel E |
| author_sort | Krass, Mark |
| collection | PubMed |
| description | Daniel E Ho and colleagues explore the legal implications of using artificial intelligence in the response to covid-19 and call for more robust evaluation frameworks |
| format | Online Article Text |
| id | pubmed-7958498 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BMJ Publishing Group Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79584982021-03-28 How US law will evaluate artificial intelligence for covid-19 Krass, Mark Henderson, Peter Mello, Michelle M Studdert, David M Ho, Daniel E BMJ Analysis Daniel E Ho and colleagues explore the legal implications of using artificial intelligence in the response to covid-19 and call for more robust evaluation frameworks BMJ Publishing Group Ltd. 2021-03-16 /pmc/articles/PMC7958498/ /pubmed/33722811 http://dx.doi.org/10.1136/bmj.n234 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions https://creativecommons.org/licenses/by-nc/3.0/igo/ This is an Open Access article distributed under the terms of the Creative Commons Attribution IGO License (https://creativecommons.org/licenses/by-nc/3.0/igo/), which permits use, distribution, and reproduction for non-commercial purposes in any medium, provided the original work is properly cited. |
| spellingShingle | Analysis Krass, Mark Henderson, Peter Mello, Michelle M Studdert, David M Ho, Daniel E How US law will evaluate artificial intelligence for covid-19 |
| title | How US law will evaluate artificial intelligence for covid-19 |
| title_full | How US law will evaluate artificial intelligence for covid-19 |
| title_fullStr | How US law will evaluate artificial intelligence for covid-19 |
| title_full_unstemmed | How US law will evaluate artificial intelligence for covid-19 |
| title_short | How US law will evaluate artificial intelligence for covid-19 |
| title_sort | how us law will evaluate artificial intelligence for covid-19 |
| topic | Analysis |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958498/ https://www.ncbi.nlm.nih.gov/pubmed/33722811 http://dx.doi.org/10.1136/bmj.n234 |
| work_keys_str_mv | AT krassmark howuslawwillevaluateartificialintelligenceforcovid19 AT hendersonpeter howuslawwillevaluateartificialintelligenceforcovid19 AT mellomichellem howuslawwillevaluateartificialintelligenceforcovid19 AT studdertdavidm howuslawwillevaluateartificialintelligenceforcovid19 AT hodaniele howuslawwillevaluateartificialintelligenceforcovid19 |